GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (NYSE:ZBH) » Definitions » Cyclically Adjusted PS Ratio

Zimmer Biomet Holdings (Zimmer Biomet Holdings) Cyclically Adjusted PS Ratio : 2.96 (As of May. 01, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Zimmer Biomet Holdings Cyclically Adjusted PS Ratio?

As of today (2024-05-01), Zimmer Biomet Holdings's current share price is $120.28. Zimmer Biomet Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $40.69. Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio for today is 2.96.

The historical rank and industry rank for Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

ZBH' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.51   Med: 4.03   Max: 5.4
Current: 2.99

During the past years, Zimmer Biomet Holdings's highest Cyclically Adjusted PS Ratio was 5.40. The lowest was 2.51. And the median was 4.03.

ZBH's Cyclically Adjusted PS Ratio is ranked worse than
57.85% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs ZBH: 2.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Zimmer Biomet Holdings's adjusted revenue per share data for the three months ended in Dec. 2023 was $9.305. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $40.69 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Chart

Zimmer Biomet Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.37 4.38 3.34 3.24 2.99

Zimmer Biomet Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.24 3.23 3.60 2.75 2.99

Competitive Comparison of Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio falls into.



Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=120.28/40.69
=2.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Zimmer Biomet Holdings's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=9.305/129.4194*129.4194
=9.305

Current CPI (Dec. 2023) = 129.4194.

Zimmer Biomet Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 6.761 99.695 8.777
201406 6.918 100.560 8.903
201409 6.441 100.428 8.300
201412 7.098 99.070 9.272
201503 6.561 99.621 8.524
201506 6.749 100.684 8.675
201509 8.567 100.392 11.044
201512 9.428 99.792 12.227
201603 9.416 100.470 12.129
201606 9.699 101.688 12.344
201609 9.033 101.861 11.477
201612 9.855 101.863 12.521
201703 9.711 102.862 12.218
201706 9.570 103.349 11.984
201709 8.888 104.136 11.046
201712 10.139 104.011 12.616
201803 9.861 105.290 12.121
201806 9.812 106.317 11.944
201809 8.942 106.507 10.866
201812 10.147 105.998 12.389
201903 9.599 107.251 11.583
201906 9.644 108.070 11.549
201909 9.142 108.329 10.922
201912 10.225 108.420 12.205
202003 8.638 108.902 10.265
202006 5.929 108.767 7.055
202009 9.253 109.815 10.905
202012 5.724 109.897 6.741
202103 7.618 111.754 8.822
202106 8.369 114.631 9.449
202109 8.003 115.734 8.949
202112 8.459 117.630 9.307
202203 7.916 121.301 8.446
202206 8.473 125.017 8.771
202209 7.940 125.227 8.206
202212 8.666 125.222 8.956
202303 8.702 127.348 8.844
202306 8.907 128.729 8.955
202309 8.350 129.860 8.322
202312 9.305 129.419 9.305

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zimmer Biomet Holdings  (NYSE:ZBH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Zimmer Biomet Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zimmer Biomet Holdings (Zimmer Biomet Holdings) Business Description

Traded in Other Exchanges
Address
345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Executives
Syed A. Jafry director 345 E. MAIN STREET, WARSAW IN 46580
Sreelakshmi Kolli director C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Christopher B Begley director
Robert Hagemann director 3 GIRALDA FARMS, MADISON NJ 07940
Michael W Michelson director 2800 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Betsy J Bernard director 711 HIGH STREET, DES MOINES IA 50392-0300
Arthur J Higgins director C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580
Chad F Phipps officer: Assoc. Gen. Counsel, Corp. Sec C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580
Zuilen Wilfred Van officer: Pres, Europe, M. East & Africa 345 E. MAIN STREET, WARSAW IN 46580
Paul A Stellato officer: VP, Controller & CAO C/O XYLEM INC, 1 INTERNATIONAL DRIVE, RYE BROOK NY 10573
Sang Yi officer: President, Asia Pacific 345 E. MAIN STREET, WARSAW IN 46580
Lori Winkler officer: SVP and CHRO 345 E. MAIN STREET, WARSAW IN 46580
Rachel Ellingson officer: SVP & CSO 345 E MAIN STREET, WARSAW K7 46580
Bryan C Hanson director, officer: President and CEO ZIMMER BIOMET HOLDINGS, 345 E. MAIN STREET, WARSAW IN 46580
Aure Bruneau officer: Group President 345 E. MAIN STREET, WARSAW IN 46580